Previous Close | 87.46 |
1-Year Change | -27.86% |
6-Months Change | 16.23% |
3-Months Change | 27.47% |
Moving Avg (50d) | 80.695 |
Moving Avg (200d) | 90.092 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 33.8B |
Beta (3-Years) | 1.14 |
Revenue Growth (ttm) | 21.85% |
Net Profit Margin (ttm) | 11.08% |
Return On Assets (ttm) | 5.72% |
EPS (ttm) | 0.91 |
PE Ratio (ttm) | 96.11 |
Dividend Yield | % |
Asset Description: | DexCom, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-12-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
89.209 | 91.833 | 93.582 | 96.206 | 100.579 | 104.952 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.